Our GSEA further revealed that CLEC4D is significantly enriched in pathways such as chronic myelogenous leukemia (CML), involving critical signaling pathways like JAK-STAT, MAPK, and PI3K-AKT (Singh et al., 2021). This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.